Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Stroke and Vascular Neurology|March 28, 2024
Assessment of Perfusion Volumes by a New Automated Software for Computed Tomography PerfusionZhixin Cao, David Wang, Xueyan Feng, et al.Neurosurgery|May 31, 2024
Quantitative Analysis of Hemodynamic Changes in Branch Arteries Covered by Flow DivertersWei You, Dachao Wei, Siming Gui, et al.Frontiers in Physiology|January 19, 2024
Automated anatomical labeling of the intracranial arteries via deep learning in computed tomography angiographyTing Chen, Wei You, Liyuan Zhang, et al.International Journal of Stroke : Official Journal of the International Stroke Society|April 7, 2026
Infarct Growth Rate and Tenecteplase Benefit in Ischemic Stroke at 4.5 to 24 Hours Without Thrombectomy --A Secondary Analysis of the TRACE-Ⅲ Randomized TrialLiyuan Wang, Li Zhou, Jinfeng Yin, et al.JAMA|May 8, 2026
Intravenous Tenecteplase Prior to Endovascular Treatment for Ischemic Stroke at 4.5 to 24 Hours: The TNK-PLUS Randomized Clinical TrialYunyun Xiong, Fengyuan Che, Hao Wang, et al.Journal of Neurointerventional Surgery|January 18, 2024
Diagnosis of intracranial aneurysms by computed tomography angiography using deep learning-based detection and segmentationWei You, Junqiang Feng, Jing Lu, et al.The New England Journal of Medicine|June 17, 2024
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without ThrombectomyYunyun Xiong, Bruce C V Campbell, Lee H Schwamm, et al.BMJ (Clinical Research Ed.)|January 7, 2026
Edaravone dexborneol versus placebo on functional outcomes in patients with acute ischaemic stroke undergoing endovascular thrombectomy (TASTE-2): randomised controlled trialChunjuan Wang, Hongqiu Gu, Xiaochuan Huo, et al.Lancet (London, England)|February 8, 2026
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trialYunyun Xiong, Fana Alemseged, Zhixin Cao, et al.Pageof 2